Arine, a San Francisco, CA-based remedy intelligence firm, raised $29M Sequence B funding.
The spherical was led by 111° West Capital, with participation from MBX Capital, New Leaf Enterprise Companions, Katalyst Ventures and Tremendous Capital Group.
The corporate intends to make use of the funds to advance the capabilities of its platform to allow value-based care at scale, and to develop its choices to channel companions throughout the value-based care continuum.
Led by CEO Yoona Kim, Arine is a medicine intelligence firm that gives a platform which permits shoppers to plan applicable, just-in-time interventions to optimize remedy remedy for his or her populations.
For the reason that firm’s launch in 2019, Arine has acquired well being plan shoppers reminiscent of nationwide, Blue Cross/Blue Defend, Medicaid, and Medicare Benefit plans, together with particular wants plans. The corporate has additionally expanded its employees to just about 100 staff.